Newsroom
December 17, 2021
Emerging evidence suggests it may be possible to treat Alzheimer’s disease by targeting therapy at senescent cells in the brain.
December 17, 2021
Chemical’s release in brain tied to processing of imagery, cells’ activation. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Dec. 17, 2021) — “Look at me!” we might say while attempting to engage our children. It turns out there is a neurochemical explanation for why looking at mom or dad actually helps kiddos pay better […]
November 8, 2021
Radiation that at first is beneficial later causes cells to senesce, promoting brain cancer’s return. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Nov. 8, 2021) — It’s a medical conundrum. Ionizing radiation, which at first extends the survival of glioblastoma patients after surgery, may later, ironically, help drive the brain cancer’s aggressive, untreatable recurrence. […]
October 19, 2021
Dr. James Lechleiter, Cell Systems and Anatomy, is quoted in this KENS 5 story. Watch story
October 14, 2021
Dr. Sudha Seshadri, Neurology, Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was a guest on Texas Public Radio’s “The Source” and discussed how UT Health San Antonio and The University of Texas Rio Grande Valley will work together to address the disproportionate impact of Alzheimer’s in Latinos at a new nationally designated Alzheimer’s Disease […]
October 8, 2021
Research that began at The University of Texas Health Science Center at San Antonio 15 years ago is nearing a significant milestone: human testing of an intravenous (IV) drug to treat brain injuries such as concussion and stroke.
